The TIMER2.0 and GEPIA datasets revealed that RNF112 mRNA was significantly downregulated in most cancers, including BLCA (Figure 1A; Figure S1A, Supporting Information). This evidence concerns the gene RNF112 and bladder transitional cell carcinoma.